Breakdown | |||||
TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
71.29M | 83.29M | 69.83M | 62.87M | 78.49M | 110.91M | Gross Profit |
51.62M | 83.29M | 28.94M | 21.73M | 35.12M | 56.35M | EBIT |
14.28M | 25.34M | -1.07M | -7.28M | 9.78M | 32.73M | EBITDA |
14.11M | 25.34M | -1.07M | 10.40M | 23.21M | 43.91M | Net Income Common Stockholders |
20.52M | 27.13M | -29.23M | 1.54M | 7.93M | 24.05M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
11.15M | 31.89M | 18.55M | 12.33M | 12.15M | 9.74M | Total Assets |
48.21M | 114.19M | 90.84M | 132.20M | 136.63M | 141.23M | Total Debt |
0.00 | 1.72M | 3.05M | 4.87M | 13.08M | 11.51M | Net Debt |
-11.15M | -30.18M | -15.50M | -7.46M | 931.00K | 1.77M | Total Liabilities |
20.82M | 25.82M | 30.97M | 45.08M | 53.29M | 58.70M | Stockholders Equity |
27.40M | 88.36M | 59.87M | 87.11M | 83.34M | 82.52M |
Cash Flow | Free Cash Flow | ||||
9.87M | 15.22M | 8.20M | 6.97M | 9.67M | 9.55M | Operating Cash Flow |
10.11M | 15.27M | 15.99M | 18.76M | 21.91M | 24.76M | Investing Cash Flow |
2.79M | 2.27M | -8.90M | -11.80M | -12.24M | -15.20M | Financing Cash Flow |
-5.26M | -1.69M | -1.63M | -6.96M | -6.44M | -9.33M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | $28.79B | 114.27 | 14.13% | 0.23% | -1.78% | 12.79% | |
70 Outperform | AU$77.15M | 3.71 | 25.65% | 4.60% | -1.32% | ― | |
70 Outperform | €9.18B | 77.40 | 34.02% | 0.89% | 17.97% | 14.29% | |
65 Neutral | $22.96B | 21.95 | 27.30% | 2.29% | -0.84% | 93.59% | |
59 Neutral | $10.72B | 10.22 | -6.67% | 3.02% | 7.42% | -11.38% | |
52 Neutral | $7.12B | ― | -2.06% | ― | -2.69% | -17.50% | |
50 Neutral | $235.18M | ― | -19.32% | ― | -13.61% | 86.37% |
Integrated Research Limited announced the cessation of certain securities, specifically 1,012,530 performance rights and 655,809 options, due to the conditions for these securities not being met or becoming incapable of being satisfied. This cessation may impact the company’s capital structure and could influence stakeholder perceptions regarding the company’s operational and financial strategies.
Integrated Research Limited has secured a significant renewal contract with JP Morgan Chase, valued at USD $6.23 million (AUD $9.80 million), for a 5-year term. This contract involves the use of IR’s Transact and Infrastructure product, which is crucial for JP Morgan Chase’s payments technology. The renewal underscores the longstanding relationship and the evolving value of IR’s technology for large enterprise clients, reinforcing its position in the industry.
Integrated Research Limited has released its half-year financial results for the period ending December 31, 2024. The announcement highlights the company’s continued focus on enhancing user experience and performance management, which is crucial for its operations and stakeholders. This release underscores the company’s strategic positioning within the industry, aiming to maintain its role as a key provider of critical system solutions to major organizations globally.
Integrated Research Limited reported significant growth in new business, with a 76% increase to $7.6 million, despite a decline in total contract and statutory revenue due to a softer renewal cycle. The company remains debt-free with strong cash reserves, focusing on a product-led growth strategy and announcing a new product launch with a major US bank as a foundation client.
Integrated Research Limited’s interim financial report for the half-year ending December 31, 2024, reveals a significant downturn, with revenues falling by 29% to A$28,839,000 and net profit dropping by 59% to A$4,572,000 compared to the same period the previous year. The company did not declare an interim dividend, reflecting the challenging financial performance, which could impact stakeholders and its market positioning adversely.
Integrated Research Limited has announced that it will release its earnings information for the half-year ending December 31, 2024, on February 20, 2025. This earnings release and subsequent conference call, led by CEO Ian Lowe and CFO Christian Shaw, is a significant event for stakeholders, offering insights into the company’s operational performance and its market positioning amid its ongoing efforts to provide innovative solutions in performance management.